Submissions

Author Guidelines

Manuscripts for Current Issues in Pharmacy and Medical Sciences can only be submitted through the online editorial system: ( https://www.editorialsystem.com/cipms/ )

All submissions are initially evaluated by an editor to determine whether they fit the aims and scope of the journal. Manuscripts considered suitable are sent for peer review before a final decision on acceptance or rejection.
Before submission, authors are responsible for obtaining permission to publish any material included in the manuscript, such as images, documents, or datasets. All listed authors must consent to be identified as co-authors. Research involving humans or animals must be approved by an appropriate ethics committee in accordance with the legal requirements of the country where the study was conducted.
Manuscripts should be written in American-English. Articles that require significant linguistic improvement may be returned to the authors prior to review. The editor may reject submissions that do not meet minimum quality standards. Before submitting your work, please ensure that it meets the following criteria:

• The study design and research argument are well-structured and clearly presented.
• The title is concise and informative.
• The abstract is self-contained and accurately reflects the content of the manuscript.

Following these recommendations increases the likelihood that reviewers will agree to evaluate the manuscript.

Scientific Quality and Relevance

The journal accepts only original manuscripts presenting current, well-designed, and scientifically sound research. Submissions should clearly state the research question, use appropriate methods, and provide reliable and up-to-date data. Manuscripts that do not meet these basic scientific standards may be rejected at the editorial screening stage.

Anti-plagiarism Check

All submitted articles are checked using the Crossref Similarity Check system (iThenticate). Only articles with an overall similarity index below 30% and a detailed analysis that does not indicate unauthorized borrowing will be considered for publication.
Articles exceeding this threshold will be forwarded to the authors for their comment and possible corrections. In cases where corrections are not possible or the authors' position does not address the concerns, the articles will not be accepted for publication.
Authors' unjustified reuse of significant portions of their own, previously published texts (self-plagiarism) is also considered a violation of ethical principles and will result in the rejection of the article.

1. Types of Articles

Current Issues in Pharmacy and Medical Sciences welcomes the following types of submissions:

• Original research articles (4,000–5,000 words).
• Review papers (6,000 words) - summary, analysis and synthesis of the current state of knowledge on a given topic.
• Short communications (2,000 words) - quick publication of significant, new, individual results or preliminary data that do not require a full, extensive research article.
• Case reports (1,500 words) - present rare, unusual, or particularly informative clinical cases.

We encourage submissions from both academic researchers and clinical practitioners, highlighting translational approaches that bridge experimental results and real-world medical applications.

2. Manuscript Preparation

Manuscript Structure

1. All original research manuscripts should include the following sections:

1. Title page – a concise and informative title clearly reflecting the subject of the study.
2. Abstract – should not exceed  to 250-300 words; summarize the aim, methods, key results, and conclusions.
3. Keywords – 3-6 words, preferably aligned with MeSH terms.
4. Introduction – background, rationale, and objectives of the study.
5. Materials and Methods – detailed description of experimental design, materials, and analytical procedures.
6. Results – presentation of findings in text, tables, and figures.
7. Discussion – interpretation of results, comparison with existing literature, study limitations, and future perspectives.
8. Conclusions – brief summary of main findings.
9. Acknowledgements (optional) – recognition of people or institutions that made a significant contribution to the work but do not meet the criteria for authorship.
10. References

2. Review papers should include the following sections: 

1. Title – short, informative, reflecting the main topic of the review.
2. Abstract – structured or descriptive - 250-300 words - includes the purpose of the review, scope, and key conclusions.
3. Keywords.
4. Introduction – presentation of the topic, clinical/scientific significance, purpose of the review, and scope (e.g., time period, type of study). 
5. Literature Search Methods (recommended for narrative reviews).
6. Main Text – the text should be logically divided into subsections.
7. Discussion – critical interpretation of the data, strengths and weaknesses of the existing literature, and identification of areas requiring further research.
8. Conclusions.
9. Acknowledgements (optional).
10. References.

3. All short communications should be written in American-English and include the following sections:

1. Title – a concise and informative title clearly reflecting the subject of the study.
2. Abstract – a short abstract (100–150 words), usually descriptive or structured, that briefly presents: the aim of the study, key findings, major conclusions.
3. Keywords.
4. Introduction – a brief background section (2–4 paragraphs) including: context and scientific rationale, the main aim of the study, justification for its importance or novelty.
5. Materials and Methods. The level of detail should be sufficient to allow reproducibility but more compact than in full-length research articles.
6. Results. 
7. Discussion. A brief interpretation of the results, usually 2–5 paragraphs: comparison with existing literature, scientific significance, primary limitations.
   Results and Discussion may be combined into a single section (Results and Discussion).
8. Conclusions. 
9. Acknowledgments (optional)
10. References. A shorter list of references (10–20 items).

4. All case reports manuscripts should be written in American-English and include the following sections:

1. Title – should include a description of the type of work, e.g., "case report".
2. Abstract – structured, short (100–150 words).
3. Keywords.
4. Introduction.
5. Case Presentation – includes: patient data (anonymized: age, gender, general description), clinical course, diagnostic tests (results, images, procedures), treatment received, response to therapy, and follow-up. Note: Colloquial, sensitive data (e.g., dates, names, full address) must be removed.
6. Discussion – interpretation of the case, comparison with the literature, what makes this case unique or informative.
7. Conclusions. 
8. Ethical consent/informed patient consent – Mandatory:“Written informed consent was obtained from the patient.”
9. Acknowledgements (optional).
10. References.

3. Title Page Requirements

The title page of the manuscript must contain all information enabling proper identification of the authors and their affiliations. Authors are asked to prepare a separate title page, which should include the following elements:

1. Title of the article (concise, informative, clearly reflecting the scope and purpose of the work, without abbreviations or ambiguous terms (unless commonly used).
2. List of authors (Authors) - The full names and surnames of all authors.
   Only individuals who have made a significant contribution to the work may be listed as authors, in accordance with ICMJE criteria. Each author must: contribute substantially to the study’s conception, execution, or data analysis, participate in drafting or critically revising the manuscript, approve the final version, accept responsibility for the integrity of the entire work.
   Individuals who do not meet authorship criteria should be acknowledged in the Acknowledgments section.
   Each submission must include a detailed description of author contributions using the CRediT taxonomy. The order of authors should be agreed upon by all contributors before submission. The editorial office does not determine or modify authorship order.
3. Author affiliations (Affiliations) - This formally identifies the institution (e.g. a university or research institute) at which the authors conducted their research and with which they are professionally or scientifically affiliated. A full affiliation includes the name of the institution, the name of the unit, clinic or department, and the city and country.
4. Corresponding author - The title page must include the contact details of the author responsible for contacting the editorial office, i.e.: name and surname, full affiliation, institutional email address (mandatory, personal email addresses should not be used as primary contact information). Optional: institutional postal address and work phone number.
5. ORCID numbers of all authors. Authors submitting their manuscripts to Current Issues in Pharmacy and Medical Sciences are requested to enter their unique ORCID (Open Researcher and Contributor ID) number. ORCID is a unique digital identifier that makes it possible to distinguish between authors with the same surname and to correctly assign publications to individuals in scientific databases. You can obtain your ORCID number free of charge at: https://orcid.org.
6. The following should also be included: information on funding sources, a declaration of conflict of interest, and information on whether the article has previously been submitted as a preprint.

4. References

References must be prepared in Vancouver style. All cited sources must be included in the reference list. Authors are encouraged to cite current, high-quality, peer-reviewed sources, preferably published within the last five years, particularly in rapidly evolving fields. Excessive self-citation should be avoided.

Key principles and examples (based on PubMed/NLM)

In-text citations: In square brackets.

Journal article (up to 6 authors):
Last Name Initials. Article title. Journal title abbreviation. Year; Volume (Number): Pages.
Example:
Doe J, Miller R. Recent advances in genetics. J Genet Res. 2021;34(4):456-478.

Journal article (more than 6 authors - et al.):
Example:
Smith J, Kowalski A, Nowak B, ... et al. Viral research. Med J. 2022;10(1):1-10.

Book:
Last Name Initials. Book title. Edition. Place of publication: Publisher; Year.
Example:
Smith J. Basics of diagnostics. 2nd ed. Warsaw: PZWL; 2020.

Electronic/internet source:
Author. Title [Internet]. Place: Publisher; Year [date of access]. Available at: URL.
Example:
Guidelines for reviewing health information [Internet]. London: NHS; 2003 [cited 2004 Jan 14]. Available from: http://www.hiquality.org.uk/.

Notes: In the case of multiple authors (more than 6), list the first six and add "et al." Journal names should be abbreviated according to the NCBI and PubMed databases.

5. Tables and Figures

• All tables and figures must have descriptive titles that accurately reflect their content.
• They should be numbered consecutively using Arabic numerals.
• Each table and figure should be self-explanatory, without the need to refer to the main text of the manuscript.
• Legends should clearly explain all abbreviations, symbols and units of measurement used.
• Graphics should be submitted in an editable format or a high-resolution format acceptable to the editor (e.g. Excel, Word, TIFF, JPEG, PNG or EPS).

6. Supplementary Materials

7. Ethical Requirements

Current Issues in Pharmacy and Medical Sciences requires that all research published in the journal follows the highest ethical standards.

1. Human Research - Any research involving human participants requires the approval of an independent ethics committee and must comply with the Declaration of Helsinki and local regulations. Authors must include the following:

• a positive decision by the ethics committee;
• a statement confirming the informed consent of the participants.

2. Animal Research - Studies involving animals must follow recognized guidelines (e.g., ARRIVE, EU Directive 2010/63/EU). Authors must provide:

• name of the animal ethics committee,
• approval number,
• confirmation that procedures minimized pain and distress.

3. Clinical Trials - Clinical trials must be registered in a WHO‑approved registry (e.g., ClinicalTrials.gov, ISRCTN). The registration number must be included in the manuscript.

4. Informed Consent - Authors must confirm that informed consent was obtained when research includes personal data, identifiable information, or participation of vulnerable groups.

5. Avoidance of Misconduct - The following are all forms of academic dishonesty: plagiarism, data fabrication or falsification, and duplicate or redundant publication. All manuscripts are checked using plagiarism detection software before being submitted to reviewers.

6. Authorship - Authorship must follow ICMJE criteria. The contribution of each author must be clearly stated (CRediT taxonomy). For transparency, authors should briefly indicate their individual contributions (e.g., conceptualization, methodology, data analysis, writing). This helps ensure clarity and good scientific practice.
   
   Changes in Authorship
   Authors are required to submit a final and complete list of authors at the time of manuscript submission and to ensure that all listed authors meet the authorship criteria and have approved the submission of the manuscript. Any changes to authorship (including the addition or removal of an author, changes in the order of authors, or changes to the corresponding author) may be considered only prior to the formal acceptance of the manuscript for publication, subject to written consent from all authors and approval by the Editorial Office.
   Once the manuscript has been accepted for publication, including preliminary or conditional acceptance, no changes to the authorship are permitted. Requests for authorship modifications submitted after acceptance will not be considered.

7. Conflicts of Interest - Authors, reviewers, and editors must disclose any conflicts of interest. A statement must be included in each manuscript.

8. Ethical Use of AI - AI tools may be used only for language assistance or data processing, and their use must be disclosed. AI cannot be listed as an author.

9. Editorial and Peer Review Ethics - Editors and reviewers must act independently, objectively, and confidentially. Reviewers must declare conflicts of interest and evaluate manuscripts fairly.

10. Response to Ethical Concerns - The journal follows COPE guidelines for handling suspected misconduct. Actions may include correction, retraction, or expression of concern.

8. Conflict of Interest Statement

Authors are required to disclose any potential conflicts of interest that may have influenced the research, interpretation of results, or preparation of the manuscript. Conflicts of interest may include:

• Financial interests (e.g., grants, consulting fees, honoraria, employment, stock ownership, paid expert testimony, funding for equipment or materials)
• Personal relationships (e.g., family, professional, or social connections)
• Academic or intellectual conflicts (e.g., academic rivalry, personal beliefs affecting objectivity)
• Institutional affiliations (e.g., connections to organizations that may benefit from the results)

One of the following statements must be included in the manuscript:

a) If a conflict of interest exists: 
“The authors declare the following potential conflicts of interest: [Provide a detailed description of the conflict—e.g., funding from Company X, consultancy for Institution Y, involvement in Project Z, etc.].”
b) If no conflicts exist: “The authors declare no conflict of interest.”

9. Funding Information

Authors are required to disclose all sources of funding that contributed to the work, including research grants, institutional funds, ministerial programs, private funds, and other forms of financial or organizational support. One of the following statements should be included in the article:

a) If the research was funded by a commercial entity: “This research was funded by:

• [name of institution/funder], project/grant number: [xxx].
• [other funding sources, if applicable].”

The sponsor had no role in the study design, data collection, data analysis, interpretation of results, or the decision to publish this manuscript.”
b) If no funding sources are listed: “The authors declare that this research did not receive external funding.”
c) If the work was indirectly supported (e.g., equipment, access to laboratories): “The authors declare that this research was supported in non-financial form by [institution] through the provision of research infrastructure.”

10. AI Usage Disclosure

Authors must disclose the use of AI tools in manuscript preparation.
AI-based tools (e.g., ChatGPT, Copilot) may be used to support the writing process, but cannot replace the author’s personal input. Authors remain fully responsible for the accuracy, content, and references of the manuscript, as well as for any potential copyright issues.

• Transparency: If AI tools were used at any stage, authors must clearly disclose their usage, including tools and prompts employed.
• Permitted Use: AI may assist with text correction, content suggestions, or bibliography management.
• Disclosure Requirement: Simple spelling or grammar corrections do not require disclosure; extensive use (e.g., content generation) must be disclosed.
• Editorial Review: Each case of AI use is evaluated individually by the editorial board.

11. Article Processing Charges (APC)

The journal applies an Article Processing Charge (APC) to cover editorial and publication costs. The APC for publication in Current Issues in Pharmacy and Medical Sciences is PLN 600 (EUR 135) (incl. VAT) per accepted manuscript. The APC fee is only charged once the manuscript has been accepted for publication.
There are no submission fees.

Bank account:

In PLN:

• Account number: 94 1020 3147 0000 8302 0084 6188
• Bank: PKO BP Oddział 1 w Lublinie

In EUR:

• Account number: PL50 1020 3147 0000 8202 0084 6253
• PKO BP S.A. O/Lublin,
  ul. Watykańska 7, 20-538 Lublin
  SWIFT: BPKOPLPW

!!! The Medical University of Lublin does not cover bank transaction costs.

Payment Note: ID of the submitted article (CIPMS-00xxx-2026-01), Name and Surname of the first author.